Visualization and Communication of Pharmacometric Models With Berkeley Madonna

Population or other pharmacometric models are a useful means to describe, succinctly, the relationships between drug administration, exposure (concentration), and downstream changes in pharmacodynamic (PD) biomarkers and clinical endpoints, including the mixed effects of patient factors and random interpatient variation (fixed and random effects). However, showing a set of covariate equations to a drug development team is perhaps not the best way to get a message across.

[1]  J. Sims,et al.  On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models. , 2010, Basic & clinical pharmacology & toxicology.

[2]  Andreas Krause,et al.  Interactive Visualization and Communication for Increased Impact of Pharmacometrics , 2010, Journal of clinical pharmacology.

[3]  Edward R. Tufte,et al.  Envisioning Information , 1990 .

[4]  Helen J. Lachmann,et al.  In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes , 2009, The Journal of experimental medicine.

[5]  D R Mould,et al.  Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development: Part 3—Introduction to Pharmacodynamic Modeling Methods , 2014, CPT: pharmacometrics & systems pharmacology.

[6]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[7]  G. Meno-Tetang,et al.  On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach. , 2005, Basic & clinical pharmacology & toxicology.

[8]  Xh Huang,et al.  Pharmacokinetic-Pharmacodynamic Modeling and Simulation. , 2007 .

[9]  Charles M. Close,et al.  Modeling and Analysis of Dynamic Systems , 1978 .

[10]  Charles Roosen,et al.  Exploring Pharmacokinetic and Pharmacodynamic Data , 2012 .

[11]  Robert H. Halstead,et al.  Matrix Computations , 2011, Encyclopedia of Parallel Computing.

[12]  Nicholas H. G. Holford,et al.  The Visual Predictive Check Superiority to Standard Diagnostic (Rorschach) Plots , 2005 .

[13]  Edward Rolf Tufte,et al.  The visual display of quantitative information , 1985 .

[14]  William S. Cleveland,et al.  Visualizing Data , 1993 .

[15]  E. Tufte.  Beautiful Evidence , 2006 .

[16]  D R Mould,et al.  Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development , 2012, CPT: pharmacometrics & systems pharmacology.

[17]  Matematik,et al.  Numerical Methods for Ordinary Differential Equations: Butcher/Numerical Methods , 2005 .

[18]  Richard Pugh,et al.  Visualization Concepts to Enhance Quantitative Decision Making in Drug Development , 2010, Journal of clinical pharmacology.

[19]  D R Mould,et al.  Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development—Part 2: Introduction to Pharmacokinetic Modeling Methods , 2013, CPT: pharmacometrics & systems pharmacology.

[20]  Ramin S. Esfandiari,et al.  Modeling and Analysis of Dynamic Systems , 2010 .

[21]  Andreas Krause,et al.  A Picture is Worth a Thousand Tables - Graphics in Life Sciences , 2013, European Journal of Histochemistry : EJH.

[22]  H. H. Rosenbrock,et al.  Some general implicit processes for the numerical solution of differential equations , 1963, Comput. J..

[23]  Andreas Krause,et al.  Concepts and Principles of Clinical Data Graphics , 2012 .

[24]  J. Gobburu,et al.  Pharmacometrics 2020 , 2010, Journal of clinical pharmacology.

[25]  M. Braga,et al.  Exploratory Data Analysis , 2018, Encyclopedia of Social Network Analysis and Mining. 2nd Ed..

[26]  J. Butcher.  Numerical methods for ordinary differential equations , 2003 .

[27]  L. Sheiner,et al.  Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check , 2001, Journal of Pharmacokinetics and Pharmacodynamics.

[28]  P. Fayers,et al.  The Visual Display of Quantitative Information , 1990 .